Celltrion said on the 24th that it received additional approval from the Ministery of Food and Drug Safety for the auto-injector (AI) formulation of the allergy disease treatment "OMLYCLO." The ...
Celltrion said on the 18th that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) recommended approval of a variation application to add an ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する